MennutiMT, ShepardTH, MellmanWJ. Fetal renal malformation following treatment of Hodgkin's disease during pregnancy. Obstet Gynecol1975; 46: 194–6.
2.
HaglerS, SchultzA, HankinH, KunstadterRH. Fetal effects of steroid therapy during pregnancy. Am J Dis Child1963; 106: 589–90.
3.
GermanJ, EhlersKH, KowalA, DeGeorgeFV, EngleMA, PassargeE.Possible teratogenicity of trimethadione and paramethadione. Lancet1970; 2: 261–2.
4.
LaverM, FairlyKF. D-penicillamine treatment in pregnancy. Lancet1971; 1: 1019–20.
5.
CrawhallJC, ScowenEF, ThompsonCJ, WattsRWE. Dissolution of cystine stones during D-penicillamine treatment of a pregnant patient with cystinuria. Br Med J1967; 2: 216–8.
6.
ScheinbergIH, SternliebI.Pregnancy in penicillamine-treated patients with Wilson's disease. N Engl J Med1975; 293: 1300–2.
7.
MarecekZ, GrafM.Pregnancy in penicillamine-treated patients with Wilson's disease. N Engl J Med1976; 295: 841–2.
8.
MjolnerodOK, RasmussenK, DommerudSA, GjeruldsenST. Congenital connective-tissue defect probably due to D-penicillamine treatment in pregnancy. Lancet1971; 1: 673–5.
9.
SolomonL, AbromsG, DinnerM, BermanL.Neonatal abnormalities associated with D-penicillamine treatment during pregnancy. N Engl J Med1977; 296: 54–5.
10.
MerkerHJ, FrankeL, GüntherT.The effect of D-penicillamine on the skeletal development of rat foetuses. Naunyn Schmiedehergs Arch Pharmacol1975; 287: 359–76.
McLachlinAE, BrownDD. Effects of penicillin administration on menstrual and other sexual cycle functions. Br J Vener Dis1947; 23: 1–10.
13.
GoldenNL, SokolRJ, RubinIL. Angel dust: possible effects on the fetus. Pediatrics1980; 65: 18–20.
14.
PettiforJM, BensonR.Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr1975; 86: 459–62.
15.
SeipM.Growth retardation, dysmorphic facies and minor malformations following massive exposure to phenobarbitone in utero. Acta Paediatr Scand1976; 65: 617–21.
MartzF, FailingerC, BlakeDA. Phenytoin terato-genesis: correlation between embryopathic effect and covalent binding of putative arene oxide metabolite in gestational tissue. J Pharmacol Exp Ther1977; 203: 231–9.
27.
WarrellDW, TaylorR.Outcome for the foetus of mothers receiving prednisolone during pregnancy. Lancet1968; 1: 117–8.
28.
SchatzM, PattersonR, ZeitzS, O'RourkeJ, MelamH.Corticosteroid therapy for the pregnant asthmatic patient. JAMA1975; 233: 804–7.
29.
ReinischJM, KarowWG, GandelmanR.Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science1978; 202: 436–8.
30.
RichmanEM, LahmanJE. Fetal anomalies associated with warfarin therapy initiated shortly prior to conception. J Pediatr1976; 88: 509–10.
31.
RuddNL, FreedomRM. A possible primidone embryopathy. J Pediatr1979; 94: 835–7.
32.
MargolinFG, KantorNM. Hemorrhagic disease of the newborn. An unusual case related to maternal ingestion of an antiepileptic drug. Clin Pediatr1972; 11: 59–60.
33.
AlexanderGJ, MachizS, AlexanderRB. Phenothiazine tranquilizers: effects of prolonged intake. Adv Exp Med Biol1972; 27: 151–60.
34.
DaltonK.Prenatal progesterone and educational attainment. Br J Psychiatry1976; 129: 438–42.
35.
KullanderS, KällenB.A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet Gynecol Scand1976; 55: 105–11.
36.
PruynSC, PhelanJP, BuchanonGC. Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol1979; 135: 485–9.
37.
GladstoneGR, HordofA, GersonyWM. Propranolol administration during pregnancy: effects on the fetus. J Pediatr1975; 86: 962–4.
38.
HabibA, McCarthyJS. Effects on the neonate of propranolol administered during pregnancy. J Pediatr1977; 97: 808–11.
39.
CottrillCM, McAllisterRG, GettesL, NoonanJA. Propranolol therapy during pregnancy, labor and delivery: evidence for transplacental drug transfer and impaired neonatal drug disposition. J Pediatr1977; 91: 812–4.
40.
LiebermanBS, StirratGM, CohenSL, BeardRW, PinkerGD. The possible adverse effect of propranolol on the fetus in pregnancies complicated by severe hypertension. Br J Obstet Gynaecol1978; 85: 678–83.
41.
FiddlerGI. Propranolol and pregnancy. Lancet1974; 2: 722–3.
42.
OakesGK, WalkerAM, EhrenkranzRA, ChezRA. Effect of propranolol infusion on the umbilical and uterine circulations of pregnant sheep. Am J Obstet Gynecol1976; 126: 1038–9.
43.
HillRM. Adverse effects of prenatal drug therapy. In: MirkinBL, ed. Clinical pharmacology and therapeutics, a pediatric perspective.Chicago: Year Book Medical Publishers, 1978: 199–219.
44.
BurrowGN, BartsocasC, KlatskinEH, GruntJA. Children exposed in utero to propylthiouracil. Subsequent intellectual and physical-development. Am J Dis Child1968; 116; 161–5.
45.
McKinnaAJ. Quinine induced hypoplasia of the optic nerve. Can J Ophthalmol1966; 1: 261–6.
46.
ReedH, BriggsJN, MartinJK. Congenital glaucoma, deafness, mental deficiency and cardiac anomaly following attempted abortion. J Pediatr1955; 46: 102–5.
47.
RobinsonGC, BrummittJR, MillerJR. Hearing loss in infants and preschool children. II. Etiological considerations. Pediatrics1963; 32: 115–24.
48.
FerrierP, WidgrenS, FerrierS.Nonspecific pseudohermaphroditism. Report of two cases with cytogenetic investigation. Helv Paediatr Acta1964; 19: 1–12.
49.
ForbesSB. The etiology of nerve deafness with particular reference to quinine. South Med J1940; 33: 613–21.
50.
MillerRW, MulvihillJJ. Small head size after atomic irradiation. Teratology1976; 14: 355–8.
51.
BoueJ, BoueA, LazarP.Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology1975; 12: 11–26.
52.
BudnickIS, LeikinS, HoeckLE. Effect in the newborn infant of reserpine administered ante partum. Am J Dis Child1955; 90: 286–9.
ShapiroS, SiskindV, MonsonRR, HeinonenOP, KaufmanDW, SloneD.Perinatal mortality and birth-weight relation to aspirin taken during pregnancy. Lancet1976; 1: 1375–6.
55.
NelsonMM, ForfarJO. Association between drugs administered during pregnancy and congenital abnormalities of the fetus. Br Med J1971; 1: 523–7.
56.
McNielJR. The possible teratogenic effect of salicylates on the developing fetus. Clin Pediatr1973; 12: 347–50.
57.
LewisRB, SchulmanJD. Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour. Lancet1973; 2: 1159–61.
58.
CollinsE, TurnerG.Maternal effects of regular salicylate ingestion in pregnancy. Lancet1975; 2: 335.
HaslamRR, EkertH, GillmanGL. Hemorrhage in a neonate possibly due to maternal ingestion of salicylate. J Pediatr1974; 84: 556–7.
61.
CollinsE, TurnerG.Salicylates and pregnancy. Lancet1973; 2: 1494.
62.
KoshakjiRP, SchulertAR. Biochemical mechanisms of salicylate teratology in the rat. Biochem Pharmacol1973; 22: 407–16.
63.
D'ErcoleAJ, ArthurRD, CainJD, BarrentineBF. Insecticide exposure of mothers and newborns in a rural agricultural area. Pediatrics1976; 57: 869–74.
64.
ButlerNR, GoldsteinH, RossEM. Cigarette smoking in pregnancy: its influence on birth weight and perinatal mortality. Br Med J1972; 2: 127–30.
65.
SimpsonWJ. A preliminary report on cigarette smoking and the incidence of prematurity. Am J Obstet Gynecol1957; 73: 808–15.
66.
NaeyeRL. Effect of maternal cigarette smoking on the fetus and placenta. Br J Obstet Gynaecol1978; 85: 832–7.
67.
ComstockGW, ShahFK, MeyerMB, AbbeyH.Low birth weight and neonatal mortality rate related to maternal smoking and socioeconomic status. Am J Obstet Gynecol1971; 111: 53–9.
68.
YerushalmyJ.Mother's cigarette smoking and survival of infant. Am J Obstet Gynecol1964; 88: 505–18.
69.
CopeI, LancasterP, StevensL.Smoking in pregnancy. Med J Aust1973; 1: 673–7.
70.
FrazierTM, DavisGH, GoldsteinH, GoldbergID. Cigarette smoking and prematurity: a prospective study. Am J Obstet Gynecol1961; 81: 988–96.
71.
MillerHC, HassaneinK, HensleighPA. Fetal growth retardation in relation to maternal smoking and weight gain in pregnancy. Am J Obstet Gynecol1976; 125: 55–60.
72.
MillerHC, HassaneinK.Maternal smoking and growth of full term infants. Pediatr Res1964; 8: 960–3.
73.
AndrewsJ, McGarryJM. A community study of smoking in pregnancy. J Obstet Gynecol Br Comm1972; 12: 1057–73.
74.
MeyerMB, JonasBS, TonasciaJA. Perinatal events associated with maternal smoking during pregnancy. Am J Epidemiol1976; 103: 464–76.
75.
MeyerMB, ComstockGW. Maternal cigarette smoking and perinatal mortality. Am J Epidemiol1972; 96: 1–10.
76.
RushD, KassEH. Maternal smoking: a reassessment of the association with perinatal mortality. Am J Epidemiol1972; 96: 183–96.
77.
RavenholtRT, LevinskiMJ, NellistDJ, TakenagaM.Effect of smoking upon reproduction. Am J Obstet Gynecol1966; 96: 267–81.
78.
RussellCS, TaylorR, LawCE. Smoking in pregnancy, maternal blood pressure, pregnancy outcome, baby weight and growth, and other related factors. A prospective study. Br J Prev Soc Med1968; 22: 119–26.
79.
PetersonWF, MoreseKN, KaltreiderDF. Smoking and prematurity. A preliminary report based on study of 7740 Caucasians. Obstet Gynecol1965; 26: 775–9.
80.
DaviesDP, GrayOP, EllwoodPC, AbernethyM.Cigarette smoking in pregnancy: associations with maternal weight gain and fetal growth. Lancet1976; 1: 385–7.
81.
NaeyeRL, LadisB, DrageJS. Sudden infant death syndrome. Am J Dis Child1976; 130: 1207–10.
82.
DunnHG, McBurneyAK, IngramS, HunterCM. Maternal cigarette smoking during pregnancy and the child's subsequent development: I. Physical growth to the age of 6 1/2 years. Can J Public Health1976; 67: 499–505.
83.
ButlerNR, GoldsteinH.Smoking in pregnancy and subsequent child development. Br Med J1973; 4: 573–5.
84.
DunnHG, McBurneyAK, IngramS, HunterCM. Maternal cigarette smoking during pregnancy and the child's subsequent development: II. Neurological and intellectual maturation to the age of 6 1/2 years. Can J Public Health1977; 68: 43–50.
85.
MeyerMB, TonasciaJA, BuckC.The interrelationship of maternal smoking and increased perinatal mortality with other risk factors. Further analysis of the Ontario Perinatal Mortality Study 1960-1961. Am J Epidemiol1975; 100: 443–52.
86.
GennserG, MarsalK, BrantmarkB.Maternal smoking and fetal breathing movements. Am J Obstet Gynecol1975; 123: 861–6.
87.
ManningF, PughEW, BoddyK.Effect of cigarette smoking on fetal breathing movements in normal pregnancies. Br Med J1975; 1: 552–3.
88.
LehlovirtaP, ForssM.The acute effect of smoking on intervillous blood flow of the placenta. Br J Obstet Gynaecol1978; 85: 729–31.
89.
QuigleyME, SheehanKL, WilkesMM, YenSSC. Effects of maternal smoking on circulating catecholamine levels and fetal heart rates. Am J Obstet Gynecol1979; 133: 685–90.
90.
PiraniBBK, MacGillivrayI.Smoking during pregnancy. Its effects on maternal metabolism and fetoplacental function. Obstet Gynecol1978; 52: 257–63.
91.
Landesman-DwyerS, EmanuelI.Smoking during pregnancy. Teratology1979; 19: 119–26.
92.
HerbstAL, UlfelderH, PoskanzerDC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med1971; 284: 878–81.
93.
HerbstAL, PoskanzerDC, RobboySJ, FriedlanderL, ScullyRE. Prenatal exposure to stilbestrol. A prospective comparison of exposed offspring with unexposed controls. N Engl J Med1975; 292: 334–9.
94.
SandbergEC. Benign cervical and vaginal changes associated with exposure to stilbestrol in utero. Am J Obstet Gynecol1976; 125: 777–89.
95.
MattinglyRF, StaflA.Cancer risk in diethylstilbestrol-exposed offspring. Am J Obstet Gynecol1976; 126: 543–5.
96.
KaufmanRH, AdamE, BinderGL, GerthofferE.Upper genital tract changes and pregnancy outcome in offspring exposed in utero to diethylstilbestrol. Am J Obstet Gynecol1980; 137: 299–308.
97.
HendersonBE, BentonB, CosgroveM, etal. Urogenital tract anomalies in sons of women treated with diethylstilbestrol. Pediatrics1976; 58: 505–7.
98.
GillWB, SchumacherGFB, BibboM.Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero. J Urol1977; 117: 477–80.
99.
FetherstonWC. Squamous neoplasia of vagina related to DES syndrome. Am J Obstet Gynecol1975; 122: 176–81.
100.
KernVG. Zur Frage der Intrauterinen Streptomycin-schädigung. Schweiz Med Wochenschr1962; 92: 77–9.
101.
ConwayN, BeitBD. Streptomycin in pregnancy: effect on the foetal ear. Br Med J1965; 2: 260–3.
102.
VarpelaE, HietalahtiJ, AroMJT. Streptomycin and dihydrostreptomycin medication during pregnancy and their effect on the child's inner ear. Scand J Respir Dis1969; 50: 101–9.
103.
MullMM. The tetracyclines. Am J Dis Child1966; 112: 483–93.
DolgerH, BookmanJJ, NechemiasC.Tolbutamide in pregnancy and diabetics. J Mt Sinai Hosp NY1969; 36: 471–4.
115.
SchiffD, ArandaJV, SternL.Neonatal thrombocytopenia and congenital malformations associated with administration of tolbutamide to the mother. J Pediatr1970; 77457–8.
116.
CoopersmithA, KerbelNC. Drugs and congenital anomalies. Can Med Assoc J1962; 87: 193.
117.
LarssonY, SterkyG.Possible teratogenic effect of tolbutamide in a pregnant prediabetic. Lancet1960; 2: 1424–5.
118.
LazarusSS, VolkBW. Absence of teratogenic effect of tolbutamide in rabbits. J Clin Endocrinol Metab1963; 23: 597–9.
119.
MoriartyAJ, NanceMR. Trifluoperazine and pregnancy. Can Med Assoc J1963; 88: 375–6.
120.
HallG.A case of phocomelia of the upper limbs. Med J Aust1963; 1: 449–50.
121.
RosenRC, LightnerES. Phenotypic malformations in association with maternal trimethadione therapy. J Pediatr1978; 92: 240–4.
122.
FeldmanGL, WeaverDD, LovrienEW. The fetal trimethadione syndrome. Am J Dis Child1977; 131: 1389–92.
GermanJ, KowalA, EhlersKH. Trimethadione and human teratogenesis. Teratology1972; 3: 349–62.
125.
EdmondsLD, AndersonCE, FlyntJW, JamesLM. Congenital central nervous system malformations and vinyl chloride monomer exposure: a community study. Teratology1978; 17: 137–42.
126.
KochharM.Cellular basis of congenital limb deformity induced in mice by vitamin A. Birth Defects1977; 13(1): 111–54.
127.
KochharDM. Studies of vitamin A-induced teratogenesis: effects on embryonic mesenchyme and epithelium, and on incorporation of H3-thymidine. Teratology1968; 1: 299–310.
128.
VorheesCV, BrunnerRL, McDanielCR, ButcherRE. The relationship of gestational age to vitamin A induced postnatal dysfunction. Teratology1978; 17: 271–6.
129.
DiSaiaPJ. Pregnancy and delivery of a patient with a Starr-Edwards mitral valve prosthesis. Obstet Gynecol1966; 28: 469–72.
130.
PauliRM, MaddenJD, KranzlerKJ, CulpepperW, PortR.Warfarin therapy initiated during pregnancy and phenotypic chondrodysplasia punctata. J Pediatr1976; 88: 506–8.
131.
ShaulWL, EmeryH, HallJG. Chondrodysplasia punctata and maternal warfarin use during pregnancy. Am J Dis Child1975; 129: 360–2.
132.
RaivioKO, IkonenE, SaarikoskiS.Fetal risks due to warfarin therapy during pregnancy. Acta Paediatr Scand1977; 66: 735–9.
133.
BeckerMH, GenieserNB, FinegoldM, MirandaD, SpackmanT.Chondrodysplasia punctata. Is maternal warfarin therapy a factor?Am J Dis Child1975; 129: 356–9.
134.
KerberIJ, WarrOS, RichardsonC.Pregnancy in a patient with a prosthetic mitral valve. JAMA1968; 203: 223–7.
135.
BarrM, BurdiAR. Warfarin-associated embryopathy in a 17-week-old abortus. Teratology1976; 14: 129–34.
MirkinBL. Perinatal pharmacology: placental transfer, fetal localization, and neonatal disposition of drugs. Anesthesiology1975; 43: 156–70.
138.
MirkinBL. Maternal and fetal distribution of drugs in pregnancy. Clin Pharmacol Ther1973; 14: 643–7.
139.
GilletteJR, MenardRH, StrippB.Active products of fetal drug metabolism. Clin Pharmacol Ther1973; 14: 680–92.
140.
LongRF, MarksJ.The transfer of drugs across the placenta. Proc Roy Soc Med1969; 62: 318–21.
141.
JuchauMR, DyerDC. Pharmacology of the placenta. Pediatr Clin North Am1972; 19: 62–79.
142.
JuchauMR, PedersenMG, FantelAG, SheppardTH. Drug metabolism by placenta. Clin Pharmacol Ther1973; 14: 673–9.
143.
JacobsonM, LevinW, PoppersPJ, WoodAW, ConneyAH. Comparison of the O-dealkylation of 7-ethoxycoumarin and the hydroxylation of benzo [a] pyrene in human placenta. Effects of cigarette smoking. Clin Pharmacol Ther1974; 16: 701–10.
144.
LevitzM, JansenV, DaviesJ.The transfer and metabolism of corticosteroids in perfused human placenta. Am J Obstet Gynecol1978; 132: 363–6.
145.
KingCTG, WeaverSA, NarrodSA. Antihistamines and teratogenicity in the rat. J Pharmacol Exp Ther1965; 147: 391–8.
146.
NarrodSA, WilkAL, KingCTG. Metabolism of meclizine in the rat. J Pharmacol Exp Ther1965; 147: 380–4.
147.
WilkAL. Relation between teratogenic activity and cartilage-binding affinity of norchlorcyclizine analogs. Teratology1969; 2: 272–4.
148.
LowreyGH. Fetal growth. In: Growth and development of children.Chicago: Year Book Medical Publishers, 1978: 55–60.
149.
Chemical teratogenesis. In: GoldsteinA, AronowL, KalmanSM, eds. Principles of drug action: the basis of pharmacology.New York: John Wiley and Sons, 1974: 703–28.
150.
PalmisanoPA, PolhillRB. Fetal pharmacology. Pediatr Clin North Am1972; 19: 3–20.
151.
ShirkeyHC. The innocent child. JAMA1966; 196: 132–5.
152.
WilsonJG. Factors determining the teratogenicity of drugs. Ann Rev Pharmacol1974; 14: 205–17.
153.
Drugs and fetal metabolism. Clin Pharmacol Ther1973; 14: 700–4.
KullanderS, KallenB, SandahlB.Exposure to drugs and other possible harmful factors during the first trimester of pregnancy. Acta Obstet Gynecol Scand1976; 55: 395–405.
163.
DegenhardtKH, KerkenH, KnörrK.Drug usage and fetal development: preliminary evaluations of a prospective investigation. Adv Exp Med Biol1972; 27: 467–79.
164.
RichardsIDG. A retrospective enquiry into possible teratogenic effects of drugs in pregnancy. Adv Exp Med Biol1972; 27: 441–55.
165.
BleyerWA, AuWYW, LangeWA, RaisyLG. Studies on the detection of adverse drug reactions in the newborn. I. Fetal exposure to maternal medication. JAMA1970; 213: 2046–8.
166.
SloneD, HeinonenOP, MonsonRR, ShapiroS, HartzSC, RosenbergL.Maternal drug exposure and fetal abnormalities. Material and methods. Clin Pharmacol Ther1973; 14: 648–53.
167.
YaffeSJ. A clinical look at the problem of drugs in pregnancy and their effect on the fetus. Can Med Assoc J1975; 112: 728–33.
168.
MedalieJH, SerrD, NeufeldHN, etal. The use of medicines before and during pregnancy — preliminary results from an epidemiological study of congenital defects. Adv Exp Med Biol1972; 27: 481–7.
169.
HarlapS, DaviesAM, HaberM, PrywesR, RossmanH, SamueloffN.Patterns of medication in early pregnancy. A preliminary report from the Jerusalem perinatal study. Adv Exp Med Biol1972; 27: 489–504.
JonesKL, SmithDW. The fetal alcohol syndrome. Teratology1975; 12: 1–10.
176.
ClarrenSK, AlvordEC, SumiSM, StreissguthAP, SmithDW. Brain malformations related to prenatal exposure to ethanol. J Pediatr1978; 92: 64–7.
177.
OuelletteEM, RosettHL, RosmanNP, WeinerL.Adverse effects on offspring of maternal alcohol abuse during pregnancy. N Engl J Med1977; 297: 528–30.
178.
OuelletteEM, RosettHL. A pilot prospective study of the fetal alcohol syndrome at the Boston City Hospital. Part II: the infants. Ann NY Acad Sci1976; 273: 123–9.
179.
SmithDW, JonesKL, HansonJW. Prospectives on the cause and frequency of the fetal alcohol syndrome. Ann NY Acad Sci1976; 273: 138–9.
180.
RosettHL. Effects of maternal drinking on child development: an introductory review. Part III. Effects of maternal drinking on child development. Ann NY Acad Sci1976; 273: 115–7.
181.
RoseltHL, OuelletteEM, WeinerLA. Pilot prospective study of the fetal alcohol syndrome at the Boston City Hospital. Part I: maternal drinking. Ann NY Acad Sci1976; 273: 118–22.
182.
LauseckerC, WithofsL, RitzN, PennerathA.A propos du syndrone dit d'alcoolisme foetal. Pediatric1976; 31: 741–7.
183.
HermierM, LeclercoF, DueH, DavidL, FrancoisR.Le nanisme intra-uterin avec debilite mentale et malformations dans le cadre de l' embryofoetopathie alcoolique. Pediatric1976; 31: 749–62.
KimmelCA, WilsonJG, SchumacherHJ. Studies on metabolism and identification of the causative agent in aspirin teratogenesis in rats. Teratology1971; 4: 15–24.
188.
BleyerWA, BreckenridgeRT. Studies on the detection of adverse drug reactions in the newborn: II. The effects of prenatal aspirin on newborn hemostasis. JAMA1970; 213: 2049–53.
189.
BlatmanS.Methadone and children. Pediatrics1971; 48: 173–5.
190.
WallachRC, JerezE, BlinickG.Pregnancy and menstrual function in narcotics addicts treated with methadone. Am J Obstet Gynecol1969; 105: 1226–9.
191.
LipsitzPJ, BlatmanS.The early neonatal period of 100 live-borns of mothers on methadone. Pediatr Res1973; 7: 404.
192.
BlinickG, WallachRC, JerezE.Pregnancy in narcotics addicts treated by medical withdrawal. Am J Obstet Gynecol1969; 105: 997–1003.
193.
NaeyeRC, BlancW, LeblancW, KhatameeMD. Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress. J Pediatr1973; 83: 1055–61.
194.
ConnaughtonJF, ReeserD, SchutJ, FinneganLP. Perinatal addiction: outcome and management. Am J Obstet Gynecol1977; 129: 679–85.
195.
FinneganLP. Management of pregnant drug-dependent women. Ann NY Acad Sci1978; 311: 135–46.
196.
GrandeF, VespaF.Indagini sulla audiotossicita trans-placentare della diidrostreptomicina. Arch Tisiol1963; 18: 772–88.
197.
BollettiM, CroattoL.Deafness in a five-year-old resulting from streptomycin therapy during pregnancy. Acta Paediatr Lat1958; 11: 1–15.
198.
LenziE, AnconaF.Sul problema delle lesioni dell'apparato uditivo da passaggio transplacentare di streptomicino. Riv ltal Ginecol1962; 46: 115.
199.
LerouxL.Existe-t-il une surdite congenitale acquise a la streptomycin. Ann Otolaryngol (Paris)1950; 67: 194–6.
200.
KhannaBK, BhatiaML. Congenital deaf mutism following streptomycin therapy to mother during pregnancy. A case of streptomycin ototoxicity in utero. Indian J Chest Dis1969; 11: 51–3.
201.
SakulaA.Streptomycin and the foetus. Br J Tuberc1954; 48: 69–72.
202.
RobinsonGC, CambonKG. Hearing loss in infants of tuberculous mothers treated with streptomycin during pregnancy. N Engl J Med1964; 271: 949–51.
203.
TaylorHM. Perinatal medication and its relation to the fetal ear. Surg Gynecol Obstet1937; 64: 542–6.
204.
WinkelCFW. Quinine and congenital injuries of ear and eye of foetus. J Trop Med Hyg1948; 51: 2–7.
205.
TonimuraT, LeeS.Discussion on the suspected teratogenicity of quinine to humans. Teratology1972; 6: 122.
206.
VarpelaE.On the effect exerted by first-line tuberculosis medicines on the foetus. Acta Tuberc Pneumol Scand1964; 35: 53–69.
207.
LedgerWJ. Antibiotics in pregnancy. Clin Obstet Gynecol1977; 20: 411–21.
208.
Center for Disease Control.Gonorrhea: CDC-recommended treatment schedules 1979. J Infect Dis1979; 139: 496–501.
209.
TottermanLE, SaxenL.Incorporation of tetracycline into human foetal bones after maternal drug administration. Acta Obstet Gynecol Scand1969; 48: 542.
210.
CohlanSQ, BevelanderG, TiamsicT.Growth inhibition of prematures receiving tetracycline. A clinical and laboratory investigation of tetracycline-induced bone fluorescence. Am J Dis Child1963; 105: 453–61.
211.
CarterMP, WilsonF.Tetracycline and congenital limb abnormalities. Br Med J1962; 2: 407–8.
212.
IngallsTH, PhilbrookFR. Monstrosities induced by hypoxia. N Engl J Med1958; 259: 558–64.
213.
CarlsonM, ReidM.Warfarin and fetal abnormality. Lancet1976; 1: 1127.
214.
HolmesLB. Prospective evaluation of newborns for malformations caused by putative teratogens. Teratology1975; 11: A22.
215.
FourieDT, HayIT. Warfarin as a possible teratogen. S Afr Med J1975; 49: 2081–3.
216.
HillRM, SternL.Drugs in pregnancy: effects on the fetus and newborn. Drugs1979; 17: 182–97.
217.
SilvermanHM. Fetal and newborn adverse drug reactions. A survey of the recent literature. Drug Intell Clin Pharm1974; 8: 690–3.
Committee on Drugs.Anticonvulsants and pregnancy. Pediatrics1979; 63: 331–3.
223.
HarrisM, CahillG, BennettP, etal. National Diabetes Data Group: classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes1979; 28: 1039–57.
224.
OakleyWG, PykeDA, TaylorKW. Diabetes and its management, 3rd ed.Philadelphia: J.B. Lippincott, 1978: 174–86.
225.
LandauerW.Is insulin a teratogen?Teratology1972; 5: 129–36.
226.
PassargeE, LenzW.Syndrome of caudal regression in infants of diabetic mothers: observation of further cases. Pediatrics1966; 37: 672–5.
227.
KarlssonK, KjellmerI.The outcome of diabetic pregnancies in relation to the mothers' blood sugar level. Am J Obstet Gynecol1972; 112: 213–20.
228.
AdashiEY, PintoH, TysonJE. Impact of maternal euglycemia on fetal outcome in diabetic pregnancy. Am J Obstet Gynecol1979; 133: 268–74.
229.
CampbellGD. Possible teratogenic effect of tolbutamide in pregnancy. Lancet1961; 1: 891–2.
230.
SterneJ.Antidiabetic drugs and teratogenicity. Lancet1973; 1: 1165.
231.
GhanemMH. Possible teratogenic effect of tolbutamide in pregnant prediabetics. Lancet1961; 1: 1227.
232.
EndeanDH, SmitGJ. Use of tolbutamide in pregnant diabetics. J Mich St Med Soc1961; 60: 1436–8.
233.
DolgerH, BookmanJJ, NechemiasC.The use of tolbutmide in the pregnant diabetic. Diabetes1967; 16: 522.
234.
BiggsJSG. Vomiting in pregnancy: causes and management. Drugs1975; 9: 299–306.
235.
SobelDE. Fetal damage due to ECT, insulin coma, chlorpromazine, or reserpine. Arch Gen Psychiatry1960; 2: 606–11.
236.
SchrierI.Trifluoperazine and foetal abnormalities. Lancet1963; 1: 174.
237.
CornerBD. Congenital malformations — clinical considerations. Med J South West1962; 77: 46–52.
238.
WheatleyD.Drugs and the embryo. Br Med J1964; 1: 630.